[1] GUSTAVSEN A,NYMO S,LANDSEM A,et al.Combined inhibition of complement and CD14 attenuates bacteria-induced inflammation in human whole blood more efficiently than antagonizing the toll-like receptor 4-MD2 complex[J].The Journal of Infectious Diseases,2016,214(1):140-150.
[2] AKIRA S,UEMATSU S,TAKEUCHI O.Pathogen recognition and innate immunity[J].Cell,2006,124(4):783-801.
[3] CHATTERJEE B,BANOTH B,MUKHERJEE T,et al.Late-phase synthesis of IκBα insulates the TLR4-activated canonical NF-κB pathway from noncanonical NF-κB signaling in macrophages[J].Science Signaling,2016,9(457):ra120.
[4] ZHU Z C,ZHENG X M,LI D,et al.Prx1 promotes the proliferation and migration of vascular smooth muscle cells in a TLR4-dependent manner[J].Molecular Medicine Reports,2017,15(1):345-351.
[5] BARRANCO C.Inflammation:soluble MRP8/14 recruits neutrophils via TLR4[J].Nature Reviews Rheumatology,2015,11(6):320.
[6] SAHASRABUDHE N M,DOKTER-FOKKENS J,DE VOS P.Particulate β-glucans synergistically activate TLR4 and Dectin-1 in human dendritic cells[J].Molecular Nutrition & Food Research,2016,60(11):2514-2522.
[7] LAPPIN M J,BROWN V,ZARIC S S,et al.Interferon-γ stimulates CD14,TLR2 and TLR4 mRNA expression in gingival fibroblasts increasing responsiveness to bacterial challenge[J].Archives of Oral Biology,2016,61:36-43.
[8] LI X Q,ZHANG Z L,TAN W F,et al.Down-regulation of CXCL12/CXCR4 expression alleviates ischemia-reperfusion-induced inflammatory pain via inhibiting glial TLR4 activation in the spinal cord[J].PLoS One,2016,11(10):e0163807.
[9] SWAROOP S,SENGUPTA N,SURYAWANSHI A R,et al.HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis[J].Journal of Neuroinflammation,2016,13:27.
[10] GE X,CAO Z,GU Y,et al.PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production[J].Molecular & Cellular Biology,2016,62(6):119-125.
[11] CHANTRATITA N,TANDHAVANANT S,SEAL S,et al.TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis[J].Clinical Microbiology and Infection,2017,23(1):47.e1-47.e10.
[12] 钟田雨,唐靖,陈登宇,等.利用荧光共振能量转移技术研究活细胞TLR4与MD-2作用结构域[J].生物化学与生物物理进展,2009,36(11):1451-1457.
[13] MCGETTRICK A F,O'NEILL L A.The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction[J].Molecular Immunology,2004,41(6/7):577-582.
[14] CHENG Y,WANG D,WANG B,et al.HMGB1 translocation and release mediate cigarette smoke-induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway[J].Molecular Biology of the Cell,2017,28(1):201-209.
[15] CIESIELSKA A,SAS-NOWOSIELSKA H,KWIATKOWSKA K.Bis (monoacylglycero) phosphate inhibits TLR4-dependent RANTES production in macrophages[J].The International Journal of Biochemistry & Cell Biology,2016,83:15-26.
[16] BOCHKOV V N,KADL A,HUBER J,et al.Protective role of phospholipid oxidation products in endotoxin-induced tissue damage[J].Nature,2002,419(6902):77-81.
[17] AKASHI S,SHIMAZU R,OGATA H,et al.Cutting edge:cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages[J].Journal of Immunology,2000,164(7):3471-3475.
[18] THOMSON A W.MyD88 inhibitors and the continuing challenge of TLR antagonism[J].Transplantation,2017,101(2):230-231.
[19] WANG Z L,WESCHE H,STEVENS T,et al.IRAK-4 inhibitors for inflammation[J].Current Topics in Medicinal Chemistry,2009,9(8):724-737.
[20] MOARBESS G,GUICHOU J F,PANIAGUA-GAYRAUD S,et al.New IKK inhibitors:synthesis of new imidazo[1,2-a]quinoxaline derivatives using microwave assistance and biological evaluation as IKK inhibitors[J].European Journal of Medicinal Chemistry,2016,115:268-274.
[21] JO H,CHOI M,KUMAR A S,et al.Development of novel 1,2,3,4-tetrahydroquinoline scaffolds as potent NF-κB inhibitors and cytotoxic agents[J].ACS Medicinal Chemistry Letters,2016,7(4):385-390.
[22] 李国逊,李宁.Toll样受体在肠黏膜屏障免疫机制的研究进展[J].肠外与肠内营养,2008,15(6):366-368,372.
[23] 胡庆丰,陈同辛.防御素研究进展[J].临床儿科杂志,2015,33(9):831-834.
[24] MUELLER T,TERADA T,ROSENBERG I M,et al.Th2 cytokines down-regulate TLR expression and function in human intestinal epithelial cells[J].Journal of Immunology,2006,176(10):5805-5814.
[25] CJOI H G,CHOI S,BACK Y W,et al.Mycobacterium tuberculosis Rv2882c protein induces activation of macrophages through TLR4 and exhibits vaccine potential[J].PLoS One,2016,11(10):e0164458.
[26] 冯丽.PrxⅠ在LPS诱导小鼠免疫反应过程中的调控作用研究[D].硕士学位论文.大庆:黑龙江八一农垦大学,2015.
[27] 沈圆圆,郭松雪.Toll样受体4抑制剂对大鼠肾缺血再灌注损伤的保护作用[J].浙江创伤外科,2015(6):1082-1085.
[28] 刘翔,林漫鹏,丁元伟,等.TLR4在益生菌治疗小鼠Hp感染中的作用[J].中国现代医学杂志.2011,21(1):32-35,40.
[29] AGOSTO L M,HIRENT J B,MICHAELS D H,et al.Porphyromonas gingivalis-mediated signaling through TLR4 mediates persistent HIV infection of primary macrophages[J].Virology,2016,499:72-81.
[30] CARTER D,FOX C B,DAY T A,et al.A structure-function approach to optimizing TLR4 ligands for human vaccines[J].Clinical & Translational Immunology,2016,5(11):e108.
[31] 周正华,马玲玲.肠易激综合征与神经-内分泌-免疫网络关系[J].中国中西医结合消化杂志,2013,21(2):106-109.
[32] BIANCHI M E.DAMPs,PAMPs and alarmins:all we need to know about danger[J].Journal of Leukocyte Biology,2007,81(1):1-5.
[33] HAMADA K,KAKIGAWA N,SEKINE S,et al.Disruption of ZO-1/claudin-4 interaction in relation to inflammatory responses in methotrexate-induced intestinal mucositis[J].Cancer Chemotherapy and Pharmacology,2013,72(4):757-765.
[34] WARDILL H R,VAN SEBILLE Y Z,MANDER K A,et al.Toll-like receptor 4 signaling:a common biological mechanism of regimen-related toxicities:an emerging hypothesis for neuropathy and gastrointestinal toxicity[J].Cancer Treatment Reviews,2015,41(2):122-128.
[35] 易宏波.抗菌肽CWA对断奶仔猪肠道炎症和肠道屏障功能的作用及其机制[D].博士学位论文.浙江:浙江大学,2016.
[36] SADEGHI K,WESSNER B,LAGGNER U,et al.Vitamin D
3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns[J].European Journal of Immunolgy,2006,36(2):361-370.
[37] 庞珊珊,乐颖影.Toll样受体4对饥饿代谢的调控作用[J].中国基础科学,2011,13(3):30-32.
京公网安备 11010802041926号